Saratoga Research & Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Saratoga Research & Investment Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-3,704	Closed	-$201K	–	43
2024 Q1	$201K	Buy	+3,704	New	+$189K	0.01%	44
2023 Q4	–	Sell	-3,713	Closed	-$216K	–	48
2023 Q3	$216K	Sell	3,713 -197	-5%	-$12.1K	0.01%	45
2023 Q2	$250K	Buy	3,910 +9	+0.2%	+$604	0.01%	43
2023 Q1	$270K	Hold	3,901	–	–	0.01%	41
2022 Q4	$281K	Hold	3,901	–	–	0.01%	42
2022 Q3	$277K	Sell	3,901 -18	-0.5%	-$1.31K	0.01%	39
2022 Q2	$302K	Hold	3,919	–	–	0.02%	42
2022 Q1	$286K	Sell	3,919 -58	-1%	-$3.89K	0.01%	44
2021 Q4	$248K	Sell	3,977 -1,366	-26%	-$80.1K	0.01%	47
2021 Q3	$316K	Hold	5,343	–	–	0.01%	40
2021 Q2	$357K	Sell	5,343 -90	-2%	-$5.87K	0.02%	37
2021 Q1	$343K	Sell	5,433 -150	-3%	-$9.33K	0.02%	38
2020 Q4	$346K	Hold	5,583	–	–	0.02%	38
2020 Q3	$337K	Sell	5,583 -62	-1%	-$3.73K	0.02%	37
2020 Q2	$332K	Hold	5,645	–	–	0.02%	38
2020 Q1	$315K	Hold	5,645	–	–	0.02%	36
2019 Q4	$362K	Sell	5,645 -65	-1%	-$3.72K	0.02%	38
2019 Q3	$290K	Hold	5,710	–	–	0.02%	39
2019 Q2	$259K	Hold	5,710	–	–	0.02%	41
2019 Q1	$272K	Hold	5,710	–	–	0.02%	41
2018 Q4	$297K	Hold	5,710	–	–	0.02%	36
2018 Q3	$354K	Hold	5,710	–	–	0.02%	37
2018 Q2	$316K	Hold	5,710	–	–	0.02%	37
2018 Q1	$361K	Hold	5,710	–	–	0.03%	34
2017 Q4	$350K	Hold	5,710	–	–	0.02%	38
2017 Q3	$364K	Hold	5,710	–	–	0.03%	36
2017 Q2	$318K	Hold	5,710	–	–	0.03%	39
2017 Q1	$311K	Hold	5,710	–	–	0.03%	38
2016 Q4	$334K	Hold	5,710	–	–	0.03%	38
2016 Q3	$308K	Sell	5,710 -435	-7%	-$27.9K	0.03%	40
2016 Q2	$452K	Hold	6,145	–	–	0.04%	33
2016 Q1	$393K	Hold	6,145	–	–	0.03%	36
2015 Q4	$423K	Sell	6,145 -1,000	-14%	-$66.1K	0.04%	37
2015 Q3	$423K	Hold	7,145	–	–	0.04%	36
2015 Q2	$475K	Sell	7,145 -100	-1%	-$6.59K	0.05%	38
2015 Q1	$467K	Sell	7,245 -190	-3%	-$11.9K	0.04%	39
2014 Q4	$439K	Hold	7,435	–	–	0.04%	40
2014 Q3	$381K	Hold	7,435	–	–	0.04%	38
2014 Q2	$361K	Hold	7,435	–	–	0.04%	45
2014 Q1	$386K	Sell	7,435 -650	-8%	-$34.6K	0.04%	40
2013 Q4	$430K	Hold	8,085	–	–	0.05%	38
2013 Q3	$374K	Sell	8,085 -100	-1%	-$4.39K	0.04%	38
2013 Q2	$366K	Buy	+8,185	New	+$355K	0.04%	40

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Saratoga Research & Investment Management's BMY Position: Q2 2024 in Review

Saratoga Research & Investment Management sold out of Bristol-Myers Squibb (BMY) in Q2 2024, closing a stake of 3,704 shares — an estimated $201K sold.

Saratoga Research & Investment Management first reported a position in BMY in Q2 2013 and held it in 43 quarters. The position peaked at $475K in Q2 2015. 2,149 funds tracked by Wall St. Rank hold BMY as of Q2 2024.

Saratoga Research & Investment Management reported no remaining Bristol-Myers Squibb position as of Q2 2024 after selling out during the quarter.
Saratoga Research & Investment Management sold 3,704 Bristol-Myers Squibb shares in Q2 2024, an estimated $201K.
Saratoga Research & Investment Management first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 43 quarters.
Saratoga Research & Investment Management's Bristol-Myers Squibb position peaked at $475K in Q2 2015.
2,149 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2024.

Based on Saratoga Research & Investment Management's 13F filing for Q2 2024, filed 16 Aug 2024.